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Introduction
Sterols  are  indispensable  eukaryotic  membrane  components, 
and serve to modulate membrane rigidity, fluidity, and perme­
ability (Maxfield and Tabas, 2005; Chang et al., 2006). Mem­
brane sterols play key roles in many important cellular processes 
ranging from membrane trafficking to signal transduction. Ab­
normal distribution and/or metabolism of cholesterol can have 
serious cellular consequences that may lead to devastating   
human diseases such as atherosclerosis (Maxfield and Tabas, 
2005). Therefore, mammalian cells have developed complex 
yet elegant mechanisms to maintain a constant level and proper 
distribution of cholesterol (Goldstein et al., 2006; Mesmin and 
Maxfield, 2009).
An important means for cells to acquire cholesterol is the 
receptor­mediated  endocytosis  of  low­density  lipoproteins 
(LDLs). The endocytic pathway sorts and delivers LDL from 
early endosomes to late endosomes/lysosomes (LEs/LYs) for 
the hydrolysis of cholesteryl esters, and the released free cho­
lesterol exits LE/LY efficiently to reach the plasma membrane 
(PM) and/or the ER for structural and regulatory functions, re­
spectively (Chang et al., 2006; Kristiana et al., 2008). The exit 
of LDL­derived cholesterol (LDL­C) from LE/LY has been   
under intensive investigation in recent years because of the   
Niemann Pick Type C (NPC) disease, an autosomal recessive and 
neurodegenerative disorder that is characterized by the accumu­
lation of LDL­C in LE/LY of cultured NPC fibroblasts (Liscum 
et al., 1989). Approximately 95% of NPC cases are caused by 
mutations in the NPC1 gene (Carstea et al., 1997), which en­
codes an LE/LY membrane protein with 13 transmembrane 
domains (TMDs) and three large lumenal loops (Davies and 
Ioannou, 2000). Mutations in NPC2 are responsible for the rest 
of NPC cases, and the NPC2 protein is a soluble, cholesterol­
binding protein that resides in the lysosomal lumen (Storch and 
Xu, 2009). Recently, the N­terminal lumenal domain of NPC1 
O
xysterol-binding protein (OSBP) and its related 
proteins (ORPs) constitute a large and evolu-
tionarily conserved family of lipid-binding pro-
teins that target organelle membranes to mediate sterol 
signaling and/or transport. Here we characterize ORP5, 
a tail-anchored ORP protein that localizes to the endo-
plasmic reticulum. Knocking down ORP5 causes choles-
terol  accumulation  in  late  endosomes  and  lysosomes, 
which is reminiscent of the cholesterol trafficking defect in 
Niemann Pick C (NPC) fibroblasts. Cholesterol appears to 
accumulate in the limiting membranes of endosomal com-
partments in ORP5-depleted cells, whereas depletion of 
NPC1 or both ORP5 and NPC1 results in luminal accumu-
lation of cholesterol. Moreover, trans-Golgi resident pro-
teins mislocalize to endosomal compartments upon ORP5 
depletion, which depends on a functional NPC1. Our   
results establish the first link between NPC1 and a cyto-
plasmic sterol carrier, and suggest that ORP5 may co-
operate with NPC1 to mediate the exit of cholesterol from 
endosomes/lysosomes.
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It has been suggested that sterol and membrane binding may 
encourage reciprocal changes in ORP conformation, facilitating 
a sterol transport cycle between donor and acceptor mem­
branes (Im et al., 2005). Indeed, all yeast ORPs and mammalian 
ORP9 have been found to be able to transfer sterol between   
liposomes in vitro, and phosphoinositides (PIPs) also play a   
key role in this transfer (Raychaudhuri et al., 2006; Ngo and 
Ridgway, 2009). In addition, the sterol transport between PM 
and ER in yeast was severely compromised when all seven yeast 
ORPs were missing (Raychaudhuri et al., 2006). Despite these 
advances, the exact location and mode of action for many mam­
malian ORPs in intracellular cholesterol trafficking remains to 
be elucidated.
In this study, we examine the cellular function of a previ­
ously uncharacterized ORP, ORP5, and we show that siRNA­
mediated knockdown of ORP5 impairs LDL­C transport to the 
ER and causes mislocalization of TGN proteins. Interestingly, 
cholesterol appears to accumulate on the limiting membranes of 
LE/LY, an effect that is dependent on a functional NPC1. Our 
results suggest that ORP5 may cooperate with NPC1 to deliver 
cholesterol from LE/LY to the ER.
Results
Interaction between yeast NPC1 and ORPs
Our laboratory previously demonstrated that the NPC1 ortho­
logue in the budding yeast, Ncr1p, localized to the limiting 
membrane of the yeast vacuole through the vacuolar protein 
sorting pathway (Zhang et al., 2004). We then attempted to 
identify interacting protein partners of Ncr1p in the budding 
yeast Saccharomyces cerevisiae by immunoprecipitation fol­
lowed by mass­spectrometric analysis. Among other proteins, 
we identified two members of yeast OSBP homologues, Osh6p 
and Osh7p (unpublished data). We confirmed the interaction be­
tween Ncr1p and Osh6/7p in vivo by using the split­ubiquitin 
yeast two­hybrid (sp­ubY2H) assay (Fig. S1, A and B; Johnsson 
and Varshavsky, 1994). Next, we investigated whether changing 
sterol levels in the vacuolar membrane affects the interaction 
between Ncr1p and Osh6p or Osh7p. We deleted the ARV1 gene 
from the wild­type reporter strain used for the sp­ubY2H system. 
arv1 mutants are temperature sensitive (Fig. S1 C) and may 
have depleted levels of sterol in vacuolar membranes (Kajiwara 
et al., 2008). We found that the interaction between Ncr1p and 
either Osh6p or Osh7p was nearly abolished in the arv1  
background (Fig. S1, D and E), which suggested that Ncr1p 
loses its affinities for Osh6p and Osh7p when vacuolar mem­
branes are depleted of sterols. We also conducted in vitro pull­
down experiments: vacuoles were isolated and incubated with 
bacterially derived Osh6–GST. Ncr1p was efficiently pulled­
down by Osh6p only in the presence of exogenous ergosterol 
ranging from 0.2 to 5 µM (Fig. 1 F). Ncr1p is highly ho­
mologous (40% identical, 75% similar) to human NPC1 
(Malathi et al., 2004; Zhang et al., 2004) and has been shown to 
be able to complement the NPC1 defect in mammalian cells 
(Malathi et al., 2004). Among all human ORPs, ORP5 shows 
highest sequence identity with Osh6/7p (National Center for 
Biotechnology Information Basic Local Alignment Search Tool 
has been shown to also bind cholesterol, but in an orientation 
that is opposite to NPC2 (Infante et al., 2008; Kwon et al., 2009). 
It has been proposed that NPC2 likely accepts and delivers 
LDL­C to the N­terminal domain of NPC1, which then inserts 
LDL­C directly into the lysosomal membrane for export (Kwon   
et al., 2009). Putative cytoplasmic cholesterol­binding proteins 
may be required to transport LDL­C from the LE/LY membranes 
to other membrane destinations for regulatory and structural 
functions (Kwon et al., 2009).
The endocytic pathway plays a critical role in cholesterol 
trafficking. Conversely, the level of cholesterol within endo­
somal compartments can also have a major impact on the sorting 
and transport of endosomal proteins at multiple steps (Gruenberg, 
2003). In yeast, sterols have been demonstrated to regulate both 
the internalization step of endocytosis and a postinternalization 
step (Heese­Peck et al., 2002). In mammalian early endosomes, 
annexin II interacts with cholesterol to regulate the biogen­
esis  of  multivesicular  transport  intermediates  destined  for   
LEs (Mayran et al., 2003). The recycling rate of GPI (glycosyl­
phosphatidylinositol)­anchored proteins through recycling endo­
somes can be greatly increased by reducing cellular cholesterol 
(Mayor et al., 1998). The role of cholesterol in the dynamics of 
LEs has been characterized in more detail because cholesterol 
can be trapped in LEs by genetic and pharmacological means. 
The motility of cholesterol­laden LEs is greatly reduced, which 
may be caused by the increased membrane association of Rab7 
(Lebrand et al., 2002). Cholesterol accumulation in NPC cells 
also interferes with the retrograde transport from endosomes to 
the TGN, which delivers receptors, enzymes, and some bacterial 
toxins to the TGN. The cation­independent mannose­6 recep­
tors (CI­MPR) localize to the TGN at steady­state but accumulate 
in NPC LEs, possibly because of increased membrane sequestra­
tion of Rab9 as a result of cholesterol accumulation (Kobayashi   
et al., 1999; Ganley and Pfeffer, 2006). These observations fur­
ther highlight the need to understand the trafficking mechanisms   
of intracellular cholesterol.
Cholesterol  transport  can  be  performed  by  membrane 
vesicles and also by carrier proteins in a nonvesicular manner, 
although the identity of these bona fide sterol carriers remains 
unclear (Yang, 2006; Prinz, 2007; Mesmin and Maxfield, 2009). 
The oxysterol­binding protein (OSBP) and its related proteins 
(OSBP­related protein [ORP]), which constitute a large con­
served protein family in eukaryotes (Ridgway et al., 1992; Yan 
and Olkkonen, 2008), have recently been characterized as puta­
tive sterol carriers. OSBP was first identified as a high­affinity 
cytosolic receptor for oxysterols, such as 25­hydroxycholesterol. 
Homologues to OSBP have subsequently been isolated in   
most eukaryotes, including 12 members in humans and 7 mem­
bers in budding yeast (Beh et al., 2001; Lehto et al., 2001).
These proteins all share a conserved 400 amino acid OSBP­
related domain (ORD) found at the C terminus of OSBP, which 
has been shown to bind cholesterol and oxysterols (Wang et al., 
2005b; Suchanek et al., 2007). In addition, OSBP and ORPs 
possess  membrane­targeting  domains/motifs,  such  as  the   
pleckstrin homology (PH) domain and an FFAT motif (diphenyl­
alanine in an acidic tract), allowing OSBP and ORPs to target 
different membranes (Wyles et al., 2002; Loewen et al., 2003). 123 ORP5 and endosomal cholesterol trafficking • Du et al.
ER­enriched, calnexin­positive fractions (Fig. 1 E). ORP8 has 
been  recently  localized  to  the  ER  via  its  C­terminal  TMD   
(Yan et al., 2008). We constructed a pmCherry­ORP8 plas­
mid and cotransfected it with pEGFP­ORP5 into HeLa cells. 
EGFP­ORP5 and mCherry­ORP8 almost completely colocal­
ized in HeLa cells, as revealed by fluorescence microscopy   
(Fig. 1 F). We also created an ORP5 truncated construct lacking 
the  predicted  C­terminal  TMD  (ORP5C).  The  truncated 
protein  lost  the reticular localization pattern (not depicted), 
similar to ORP8C (Yan et al., 2008). These data demonstrate 
that ORP5, like ORP8, is also anchored in the ER membrane via 
its C­terminal TMD.
ORP5 transports sterols in vitro
ORP5  has  been  shown  to  bind  cholesterol  and  25­hydroxy­
cholesterol in a photo­cross­linking assay in live cells (Suchanek   
et  al.,  2007).  However,  the  ORP5–cholesterol  interaction  is 
weak and it is unclear whether ORP5 can transfer sterols from 
the donor to the acceptor membrane directly. To test whether 
ORP5 can transport sterols in vitro, we purified the ORDs of 
ORP5 and yeast Osh4p, and performed a sterol transfer assay as 
described previously (Schulz et al., 2009). The assay was per­
formed between dehydroergosterol (DHE)­incorporated donor 
liposomes and dansyl­phosphatidylethanolamine (dansyl­PE)–
incorporated acceptor liposomes in the absence or presence of 
various PIPs with 40 pmol of purified proteins. The energy 
transfer between DHE and dansyl­PE in the acceptor liposomes 
[BLAST] E value, 2 × 10
57; Altschul et al., 1990). Led by the 
interaction between Ncr1p and Osh6/7p in yeast, we next aim to 
characterize the mammalian ORP5 and investigate its role in 
NPC1­mediated cholesterol trafficking.
ORP5 localizes to the ER through its  
C-terminal TMD
Human  ORP5  is  ubiquitously  expressed  (unpublished  data). 
Like OSBP and ORP8, ORP5 has a well­conserved PH domain 
near its N terminus and ORD near its C terminus. Similar to 
ORP8 but different from all other mammalian ORPs, ORP5 has 
a putative C terminal TMD (Fig. 1 A). To gain insights into sub­
cellular localization of ORP5, we tagged EGFP to the N terminus 
of ORP5 and transfected HeLa cells with the pEGFP­ORP5 
plasmid  and  pDsRed2­ER  (an  ER  marker).  Expression  of 
EGFP­ORP5 showed an ER­like reticular fluorescence pattern 
(Fig. 1 B), which suggests that ORP5 associates with ER mem­
branes. Endogenous ORP5, which was detected by immuno­
fluorescence  staining  using  a  goat  polyclonal  antibody  to 
N­terminal amino acids 2–14 of human ORP5, also colocalized 
with the ER marker (Fig. 1 C). The specificity of immunofluor­
escence staining was assessed in cells treated with siRNA 
against ORP5. As shown in Fig. 1 D, ORP5 staining was clearly 
seen in control cells but became much weaker in cells treated 
with siRNA targeting the endogenous ORP5. The ER localiza­
tion of ORP5 was further confirmed by subcellular fraction­
ation. In HeLa cells, ORP5 was predominantly detected in 
Figure 1.  ORP5 localizes to the endoplasmic reticulum. (A) Schematic diagram of the domain structures of human OSBP, ORP5, and ORP8. FFAT, diphenyl-
alanine in an acidic tract. (B) HeLa cells grown on coverslips in medium A were cotransfected with EGFP-ORP5 and DsRed-ER for 24 h and processed   
for confocal fluorescence microscopy. Representative confocal images are shown. (C) HeLa cells grown on coverslips in medium A were cotransfected with 
DsRed-ER for 24 h and processed for immunofluorescence staining with a goat polyclonal antibody to ORP5. Specificity of staining was verified by using 
normal goat IgG as a negative control in the experiment. Representative confocal images are shown. (D) HeLa cells grown in medium A were transfected 
with siRNA against ORP5 (siORP5) or a universal control siCTRL for 72 h, followed by processing for immunofluorescence staining as in C. Representative 
confocal images are shown. (E) Subcellular distribution of ORP5. Subcellular fractionation of membranes from HeLa cells was performed as described 
in Materials and methods. The migration of ORP5, ER (calnexin), LY (Lamp-1), and Golgi (-1,4-galactosyltransferase I, -1,4GT1) markers with the   
approximate molecular weights is shown. (F) HeLa cells grown on coverslips in medium A were cotransfected with EGFP-ORP5 and mCherry-ORP8 for   
24 h followed by processing for confocal fluorescence microscopy. Bars, 10 µm.JCB • VOLUME 192 • NUMBER 1 • 2011   124
(ACAT) is located (Kristiana et al., 2008). Cells were starved of 
cholesterol and treated with radio­labeled fatty acids together 
with LDL. Lipids extracted from cells were separated by TLC, 
and the formation of radio­labeled cholesteryl esters catalyzed 
by ACAT was visualized by phosphorimaging (Fig. 3 D).   
We then quantified relative cholesterol esterification by densi­
tometry and normalized the values to those of the cells trans­
fected with control siRNAs (Fig. 3 E). As expected, NPC1 
knockdown blocked LDL­C transport to the ER and almost 
completely abolished cholesterol esterification activity in HeLa 
cells (Fig. 3 D, lane 4; and Fig. 3 E). Consistent with the filipin 
staining results, ORP5 knockdown in HeLa cells reduced the 
rate of cholesterol esterification by nearly 50% (Fig. 3 D, lane 6; 
and Fig. 3 E).
Cholesterol accumulates on the  
limiting membrane of LE/LY in ORP5 
knockdown cells
Given  the  phenotypic  similarity  between  NPC1  and  ORP5 
knockdown cells, we next investigated the possible functional 
interactions between ORP5 and NPC1. We were able to knock 
down ORP5 and NPC1 expression simultaneously (Fig. 4 A, 
lane  4). The  rate  of  cholesterol  esterification  was  decreased 
similarly between NPC1 single and NPC1/ORP5 double knock­
down cells (Fig. 4 B). A closer examination of the filipin stain­
ing pattern of ORP5 knockdown cells revealed that cholesterol 
appears to accumulate in large, ring­like punctate structures, 
and that cholesterol is concentrated on the limiting membrane 
of these compartments (Fig. 4 C, siORP5, bottom; and Fig. S5 B). 
Colocalization studies showed that most of these compartments 
were Lamp1­positive LE/LY, and that cholesterol overlapped 
with Lamp1, a limiting membrane protein of LE/LY (Fig. 4 D). 
In contrast, cholesterol appeared to fill the whole LE/LY com­
partment in NPC1 knockdown cells (Fig. 4, C and E). Interest­
ingly,  the  pattern  of  cholesterol  distribution  in  NPC1/ORP5 
double knockdown cells was identical to that of NPC1, but not 
ORP5 single knockdown cells (Fig. 4 C). Together, these obser­
vations suggest that ORP5 may cooperate with NPC1 in facilitat­
ing the egress of LDL­C from LE/LY, and that the ORP5 function 
depends on a functional NPC1.
Knockdown of ORP5 causes mislocalization 
of trans-Golgi proteins to endosomal 
compartments, and this effect depends on 
a functional NPC1
As the knockdown of another ORP, ORP9, disrupted the Golgi, 
which subsequently caused cholesterol accumulation in the   
endosomes (Ngo and Ridgway, 2009), the effect of ORP5 
knockdown  on  cholesterol  trafficking  may  be  indirect.  We 
therefore examined the morphology of the ER, lipid droplets, 
and Golgi in ORP5 knockdown cells. Lipid droplet staining 
was performed with LipidTOX, and fluorescence microscopy 
revealed  that  lipid  droplet  formation  remained  unaltered  in 
ORP5 knockdown cells, and that accumulated cholesterol in 
these cells was not associated with lipid droplets (Fig. S2 B, 
insets). We also transfected cells with the ER marker DsRed2­ER 
to see if the ER structure was affected. No gross alteration of ER 
reflects  DHE  transfer  from  donor  to  acceptor  membranes.   
We found that purified ORP5ORD can transfer DHE in vitro at 
a similar rate to that of Osh4p (Fig. 2). The addition of PIPs, 
such as PI(3)P, PI(3,5)P2, or PI(4,5)P2, to the donor membranes 
did not seem to affect the transfer rate, except for PI(4)P, which 
appeared to partially inhibit DHE transfer by ORP5ORD (Fig. 2). 
These results suggest that ORP5 is able to transfer cholesterol 
in vitro and that the transfer may be affected by certain lipid 
compositions (e.g., PI4P) of donor membranes.
Knockdown of ORP5, but not ORP8, 
impairs the transport of LDL-C to the ER
To assess the in vivo role of ORP5 in intracellular cholesterol 
transport, HeLa cells were used as a model because we were 
able to efficiently silence ORP5 and NPC1 expression using 
siRNA in these cells (Fig. 3 A). siRNA­transfected cells were 
incubated with LDL overnight, and filipin staining experiments 
were performed to detect LDL­C. NPC1 depletion produced   
a typical LDL­C staining pattern that is usually seen in NPC1­
deficient cells (Fig. 3 B). Interestingly, cholesterol accumula­
tion also occurred in ORP5 knockdown cells, but not in ORP8 
knockdown cells (Fig. 3 B). A significant increase of intracellu­
lar free cholesterol in ORP5 and NPC1 knockdown cells was 
detected when cytoplasmic filipin fluorescence was quantified 
as described previously (Fig. S2 A; Ge et al., 2008). To bio­
chemically determine the cholesterol content in siRNA­transfected 
cells, we measured the amounts of total cholesterol in cells with 
the same treatment. Consistent with the filipin staining observa­
tion, the total and free cholesterol content was increased in both 
NPC1 and ORP5 knockdown cells, but not in ORP8 knockdown 
cells (Fig. 3 C). This, together with the intracellular, endosome/
LY­like filipin staining pattern, indicates that ORP5 may be in­
volved in the intracellular transport of LDL­C.
To further investigate the effect of ORP5 knockdown on 
LDL­C transport to the ER, we performed a cholesterol esteri­
fication assay, which is a standard measurement of cholesterol 
transport to the ER, where Acyl­CoA:cholesterol acyltransferase 
Figure 2.  ORP5 transfers sterols in vitro. DHE transfer by 40 pmol of 
purified  ORP5LBD  from  donor  to  acceptor  liposomes  was  determined   
fluorometrically as described in Materials and methods. The amount of 
DHE transferred in 1 h (30°C) was calculated and the transferred DHE in 
the absence or presence of different species of PIPs is shown. The results 
are expressed as means + SD (error bars) and are representative of two 
independent experiments.125 ORP5 and endosomal cholesterol trafficking • Du et al.
punctate localization in the majority of ORP5 knockdown cells, 
and  cholesterol  colocalized  with  these  structures  (Fig.  5  C), 
which indicates a mislocalization of DsRed­Golgi to endo­
somal compartments but not fragmentation of the Golgi. Indeed, 
careful examination of Golgi structure by various markers   
indicated  an  intact  Golgi  (Fig.  S2,  D  and  E).  Therefore, 
DsRed­Golgi  appeared  to  be  trapped  in  cholesterol­filled   
LE/LY upon ORP5 knockdown. Most interestingly, in NPC1/
ORP5  double  knockdown  cells,  the  localization  of  DsRed­
Golgi appeared to be broadly similar to that observed in control   
or NPC1 knockdown cells (Fig. 5, D and E), where the accu­
mulated LDL­C was clearly not associated with DsRed­Golgi   
structure was observed at the resolution of light (fluorescence) 
microscopy in ORP5 knockdown cells compared with NPC1 
knockdown or control cells (Fig. S2 C). We next transfected 
RNAi­treated cells with the fluorescently tagged Golgi marker 
DsRed­Monomer Golgi (DsRed­Golgi), which expresses Ds­Red 
fused with the N­terminal 81 amino acids of 1,4­galactosyl­
transferase  (Fig.  5, A–D).  Similar  to  control  cells,  NPC1 
knockdown showed no significant impact on the localization 
of the DsRed­Golgi (Fig. 5, A and B). LDL­C that accumu­
lated within LE/LY in NPC1 knockdown cells was clearly disso­
ciated from the Golgi marker (Fig. 5 B, merged image inset).   
In contrast, the DsRed­Golgi displayed a much more dispersed, 
Figure 3.  ORP5 knockdown causes endosomal cholesterol accumulation and inhibits LDL-stimulated cholesterol esterification. (A) HeLa cells grown in me-
dium A were transfected with siNPC1, siORP5, siORP8, or a universal control siCTRL for 48 h, followed by transfection with pcDNA4-ORP5 or pmCherry-
ORP8 for 24 h. Efficiency of knockdown was analyzed by immunoblotting using polyclonal anti-NPC1, anti-ORP5, or anti-DsRed antibodies. The molecular 
mass of the proteins is indicated in kilodaltons. (B) HeLa cells grown in medium A were transfected with the indicated siRNAs for 54 h. Cells then received 
medium D supplemented with 50 µg/ml LDL for 18 h followed by processing for filipin staining. Fluorescent images are representative of four independent 
experiments with similar results. Bars, 10 µm. (C) Cells that received the same treatments as in B were lysed by 0.1 M NaOH and processed for measuring 
cellular free cholesterol as described in Materials and methods. Values were normalized to total cell proteins and are relative to siCTRL-transfected cells. The 
results are expressed as means + SD (error bars). **, P < 0.01. (D) HeLa cells grown in medium A were transfected with the indicated siRNAs for 48 h,   
followed by incubation in medium D for 18 h. Cells were then chased with LDL (50 µg/ml) and [
14C]-palmitate in medium D for 6 h. Lipids extracted from 
cell lysates were standardized for total cell proteins and separated by TLC. Cholesteryl [
14C]-esters were revealed by phosphorimaging. A representative 
phosphorimage of three experiments with similar results is shown. TG, triacylglycerols; *, unknown nonspecific lipids. (E) Quantification of cholesteryl 
[
14C]-esters formed in D by densitometry. Values of siCTRL + LDL were arbitrarily set as 100, against which experimental data were normalized. The results 
are expressed as means + SD (error bars) and are representative of three independent experiments. Significant differences were show between siCTRL and 
siNPC1 or siORP5 in the presence of LDL. **, P < 0.01.JCB • VOLUME 192 • NUMBER 1 • 2011   126
which further indicates a specific role of ORP5. Collectively, 
these results provide further evidence that ORP5 may be in­
volved in endosomal LDL­C transport and may functionally 
interact with NPC1.
(Fig. 5 D, merged image inset). These data suggest that the 
mislocalization  of  DsRed­Golgi  to  the  LE/LY  upon  ORP5 
knockdown depends on a functional NPC1. These effects were 
not  observed  in  ORP8  knockdown  cells  (unpublished  data), 
Figure 4.  Cholesterol accumulates on the limit-
ing membrane of LE/LY in ORP5 knockdown 
cells. (A) HeLa cells grown in medium A were 
transfected  with  siNPC1,  siORP5,  siNPC1, 
and siORP5, or a universal control siCTRL for 
48 h, followed by transfection with pcDNA4-
ORP5 for 24 h. Efficiency of knockdown was 
analyzed by immunoblotting using polyclonal   
anti-NPC1, anti-ORP5 antibodies. The molecu-
lar mass of the proteins is indicated in kilo-
daltons next to the gel blot. (B) HeLa cells grown   
in medium A were transfected with the indicated 
siRNAs for 48 h, followed by incubation in me-
dium D for 18 h. Cells were then chased with   
50 µg/ml LDL and [
14C]-palmitate in medium D   
for  6  h.  A  cholesterol  esterification  assay   
was performed as described in Fig. 3 D, and 
relative cholesterol esterification was quantified 
as described in Fig. 3 E. The results are ex-
pressed as means + SD (error bars). (C) HeLa 
cells grown in medium A were transfected with 
indicated siRNAs for 54 h. Cells then received 
medium D supplemented with 50 µg/ml LDL for 
18 h followed by processing for filipin staining. 
Fluorescent images are representative of four 
independent  experiments  with  similar  results. 
Bars, 10 µm. (D and E) HeLa cells grown in 
medium A were transfected with siORP5 (D) or 
siNPC1 (E) for 48 h, followed by transfection 
with pEYFP-Lamp1 for 6 h. Cells then received 
medium D supplemented with 50 µg/ml LDL for 
18 h followed by processing for filipin staining 
and fluorescence microscopy. Enlarged views 
of the boxed regions are shown in the bottom 
panels.  Arrows  indicate  the  overlapping  of 
accumulated  cholesterol  with  EYFP-Lamp-1  in 
ORP5 knockdown cells but not in NPC1 knock-
down cells. Bars, 10 µm.127 ORP5 and endosomal cholesterol trafficking • Du et al.
but is mostly present in the TGN at steady­state. HeLa cells   
depleted of NPC1 or ORP5 were double­stained for endogenous 
CI­MPR or the Golgi marker Golgin 97. CI­MPR, but not   
Golgin 97, showed a much more dispersed localization in cells de­
pleted for ORP5 than normal cells or cells depleted for NPC1 
(Fig. 6, A and B). Consistent with these observations, the green 
fluorescence profile (CI­MPR) was much broader in ORP5 
The TGN plays a central role in protein sorting and re­
ceives  proteins  by  retrograde  transport  from  the  endosomes 
(Bonifacino and Rojas, 2006). Our results indicate that ORP5 
knockdown causes cholesterol accumulation in the endosomes, 
resulting in partial disruption of the retrograde transport path­
way (Fig. 5). To investigate this further, we examined the local­
ization of the CI­MPR, which is recycled between LE and TGN 
Figure  5.  The  localization  of  DsRed-Golgi  in   
cells depleted for ORP5, NPC1, or both. (A–D) HeLa 
cells  grown  in  medium  A  were  transfected  with   
siCTRL (A), siNPC1 (B), siORP5 (C), or siNPC1 and 
siORP5 (D) for 48 h, followed by transfection with 
the Golgi marker DsRed-Golgi for 6 h. Cells were 
treated with 50 µg/ml LDL in medium D for 18 h 
followed by processing for filipin staining. Confocal 
fluorescence images are shown. Data are represen-
tative of three independent experiments with similar 
results. Enlarged views of the boxed regions are 
shown in the insets. Bars, 10 µm. (E) Quantification 
of DsRed-Golgi mislocalization in A–D. Values are 
the percentage of transfected cells with mislocal-
ized DsRed-Golgi marker (means + SD [error bars], 
n > 80; **, P < 0.01).JCB • VOLUME 192 • NUMBER 1 • 2011   128
Figure 6.  Depletion of ORP5 impairs the transport of CI-MPR and TGN46, but not STxB. (A) HeLa cells were transfected with the indicated siRNAs for   
72 h, followed by double-labeling with antibodies to CI-MPR and giantin. Confocal images are shown to indicate a more dispersed distribution of CI-MPR 
in cells treated with siORP5 rather than with siNPC1. Individual fluorescent profiles in merged images were quantified using the Olympus FluoView version 
2.0 Viewer software and are shown on the right. (B) Quantification of cells with dispersed CI-MPR in A. Values are the percentage of cells with dispersed 
localization of CI-MPR (means + SD [error bars], n > 100; *, P < 0.05; **, P < 0.01). (C) HeLa cells were transfected with the indicated siRNA for 72 h, 
incubated on ice for 10 min, and chased with mouse monoclonal antibodies to CI-MPR for 30 min on ice. Antibody internalization was performed at 37°C 
for 60 min. Cells were then fixed by 4% paraformaldehyde, and internalized CI-MPR was detected using Alexa Fluor 488–conjugated goat anti–mouse 
antibodies. (D) HeLa cells were transfected with the indicated siRNAs for 72 h, followed by labeling with antibodies to TGN46. Confocal images are 
shown to indicate a dispersed distribution of TGN46 in cells treated with siORP5. (E) Quantification of cells with dispersed TGN46 in D. Values are the 
percentage of cells with dispersed localization of TGN46 (means + SD [error bars], n > 100; **, P < 0.01). Data are representative of three independent 
experiments with similar results. (F) HeLa cells, transfected with the indicated siRNA for 72 h in medium A, were incubated with Cy3-conjugated STxB in 
DME, 1% BSA, and 25 mM Hepes, pH 7.4, for 15 min at 37°C. Cells were washed in PBS and incubated for 1 h at 37°C in medium A before fixation by 
4% paraformaldehyde, followed by labeling with antibodies to giantin. Bars, 10 µm.129 ORP5 and endosomal cholesterol trafficking • Du et al.
knockdown cells than that in control or NPC1 knockdown cells 
(Fig. 6 A, right). We also performed a CI­MPR antibody internal­
ization assay to monitor the endosomal trafficking of endoge­
nous CI­MPR in HeLa cells. As shown in Fig. 6 C, depletion   
of ORP5 has much more severe effects on retrograde transport 
of CI­MPR than that of NPC1 depletion. We next examined the 
effects of ORP5 depletion on the trafficking of TGN46 and 
Shiga toxin subunit B (STxB), two other model cargos that   
cycle between the PM and TGN. Both TGN46 and STxB reach 
the TGN via early but not LEs, whereas STxB may also transit 
through the recycling endosomes (Lieu and Gleeson, 2010).   
In contrast to NPC1 depletion, ORP5 knockdown caused dramatic, 
dispersed distribution of TGN46 (Fig. 6, D and E). Neither 
NPC1 nor ORP5 knockdown, however, had any apparent effect 
on the trafficking of STxB to the TGN (Fig. 6 F). These results 
suggest that ORP5 knockdown affects trafficking events through 
early and late but probably not recycling endosomes. The traf­
ficking defects could likely result from the accumulation of 
LDL­C in endosomal compartments in the absence of ORP5.
To ascertain the specificity of the effects observed upon 
depletion of ORP5, we performed rescue experiments in which 
the RNAi­treated cells were transfected with GFP­ORP5 under 
a cytomegalovirus promoter. Although GFP­ORP5 was depleted 
drastically, a significant amount of the protein still remained 
(Fig. S3 A). The mislocalization of DsRed­Golgi was almost 
completely rescued in cells expressing GFP­ORP5 (Fig. S3 B). 
Interestingly, expression of the ORD domain of ORP5, which 
was not targeted by the siRNA, also corrected the mislocaliza­
tion of Ds­Red Golgi due to depletion of ORP5 (Fig. S3 B).   
In a separate approach, we generated RNAi­resistant ORP5 con­
structs by introducing silent mutations into the wild­type ORP5 
sequence targeted by siRNA. Although the expression of EGFP 
did not affect intracellular cholesterol accumulation in ORP5­
depleted cells, the expression of RNAi­resistant EGFP­ORP5 
significantly alleviated accumulated cholesterol, as revealed by 
filipin staining (Fig. 7 A). Similarly, only those cells that ex­
pressed fluorescent protein–tagged, RNAi­resistant ORP5 re­
stored  normal  localization  of  TGN46  and  CI­MPR  in  cells 
transfected with siRNA against ORP5 (Fig. 7, B and C), which 
further confirmed the specificity of ORP5 knockdown effects.
ORP5 coimmunoprecipitates with NPC1
Given the functional connections between NPC1 and ORP5, it 
is likely that NPC1 and ORP5 may function in the same multi­
protein complex that mediates the export of cholesterol from 
LE/LY. To test this possible physical link, we first performed 
coimmunoprecipitation (coIP) experiment in HEK293 cells.   
We cotransfected HEK293 cells with cDNAs encoding the   
C­terminal ligand­binding domain (amino acids 266–826) of   
ORP5 (ORP5LBD; Suchanek et al., 2007) and NPC1, or a negative 
control (GFP). We found that ORP5LBD could pull down YFP­
tagged NPC1 but not GFP alone (Fig. S3 C, IP: Xpress, lane   
2 vs. 3). Conversely, YFP­tagged NPC1, but not GFP, could pull 
down ORP5LBD (Fig. S3 C, IP: GFP, lane 2 vs. 3). We then   
attempted to address whether transiently expressed ORP5 can be 
immunoprecipitated by endogenous NPC1 in CHO cells. We chose 
CHO cells because we have in routine use an NPC1­deficient   
CHO cell line (the 2­2 cell line, a gift from L. Liscum). The 
mutant cell line lacks a mature NPC1 (Wojtanik and Liscum, 
2003) and was therefore used as a negative control in our experi­
ment. We transfected wild­type CHO­K1 and mutant 2­2 cells 
with cDNAs encoding ORP5LBD or mock vector as a control. 
Transiently  expressed  ORP5LBD  was  coimmunoprecipitated 
with NPC1 in CHO­K1 cells (Fig. 8 A, lanes 1 and 2) but not in 
mutant 2­2 cells (Fig. 8 A, lane 4).
Next, we examined whether mutations in NPC1 could affect 
the ORP5–NPC1 interaction. A single amino acid change in the 
sterol­sensing domain of NPC1 (P692S) has been previously 
shown to abolish cholesterol binding (Ohgami et al., 2004) and 
Figure 7.  Rescue effects of ORP5 expression. (A) HeLa cells grown in 
medium A were transfected with siORP5 for 48 h, followed by transfec-
tion with EGFP alone or RNAi-resistant GFP-OPR5 (GFP-ORP5-siR) for 6 h. 
Cells then received medium D supplemented with 50 µg/ml LDL for 18 h 
followed by processing for filipin staining and fluorescence microscopy.   
Images are shown to indicate that cholesterol accumulation was significantly 
alleviated in GFP-ORP5-siR–expressing cells (71 ± 2%) but not in GFP- 
expressing cells (5 ± 3%). (B) HeLa cells grown in medium A were trans-
fected with siORP5 for 48 h, followed by transfection with RNAi-resistant 
GFP-OPR5  for  24  h.  Cells  were  fixed  and  labeled  with  antibodies  to 
TGN46. Confocal images are shown to indicate that the dispersed dis-
tribution of TGN46 was rescued in cells expressing GFP-ORP5. (C) HeLa 
cells grown in medium A were transfected with siORP5 for 48 h, followed 
by transfection with RNAi-resistant mCherry-OPR5 for 24 h. Cells were 
fixed and labeled with antibodies to CI-MPR. Confocal images are shown 
to indicate that the dispersed distribution of CI-MPR was rescued in cells 
expressing mCherry-ORP5. Bars, 10 µm.JCB • VOLUME 192 • NUMBER 1 • 2011   130
represents a loss­of­function mutation of the protein (Millard   
et al., 2005). Thus, NPC1­P692S mutant was unable to comple­
ment the NPC phenotype in NPC1­deficient 2­2 cells, as indi­
cated by filipin staining (not depicted). In contrast, NPC1­D787N, 
a gain­of­function mutant (Millard et al., 2005), could correct 
the accumulation of free cholesterol in 2­2 cells (unpublished 
data). We  transfected  HEK­293  cells  with  full­length  ORP5 
cDNA together with plasmids encoding YFP­tagged wild­type 
NPC1 or either of the two mutants. ORP5 was immunoprecipi­
tated by a polyclonal anti­GFP antibody in the presence of   
wild­type  NPC1,  NPC1­P692S,  or  NPC1­D787N  (Fig.  8  B, 
lanes 2–4). These data suggest that the two mutations within the 
sterol­sensing domain of NPC1 have no effects on the ORP5–
NPC1 interaction.
How would an ER resident protein associate with an   
endosomal membrane protein? It is known that ER can form 
transient junctions with other organelles, such as mitochondria 
(Kornmann et al., 2009). Recently, it has been established that 
membrane contacts between endosomes and ER enable inter­
action between ER and endosomal membrane proteins (Eden   
et al., 2010). In addition, cholesterol and ORP1L regulate the 
formation of ER–LE contact sites where the ER protein VAP 
interacts in trans with the Rab7­RILP receptor to control the   
intracellular positioning of the LEs (Rocha et al., 2009). It is 
therefore likely that ORP5 may also transiently associate with 
LEs. ORP5 predominantly localizes to the ER at steady­state 
due to the tail anchor (Fig. 1), and we reason that if ORP5 does 
associate with LEs, ORP5 may localize to LEs upon removal   
of  the  tail  anchor.  Indeed,  ORP5  without  its  tail  anchor   
(ORP5­C) was found in the cytoplasm and also in punctate 
structures (in 30% of transfected cells), which partially colocal­
ized with Lamp1 and NPC1 but not EEA1, an early endosomal 
marker (Fig. 8 C).
Discussion
NPC1 and NPC2 are key proteins that govern the exit of LDL­C   
from LE/LY compartments. Recent elegant biochemical and 
crystallographic studies suggest that NPC2 delivers LDL­C to 
the N­terminal domain of NPC1, which then inserts the cho­
lesterol into the lysosomal membrane for export (Kwon et al., 
2009). How cholesterol moves from the lysosomal membrane 
to the PM and ER, and whether NPC1 or other proteins play a 
role in this process, remains unknown. As an attractive model, 
cytoplasmic sterol­binding proteins such as OSBP/ORPs could 
extract cholesterol molecules from LE/LY membranes and de­
liver them directly to the ER or the PM. However, little evi­
dence exists to support such a hypothesis. LDL­C may also take 
Figure 8.  ORP5 coimmunoprecipitates with NPC1 and interacts with LEs. 
(A) CHO-K1 and 2–2 (Npc1-null) cells grown in medium B were trans-
fected with the indicated cDNAs for 6 h. PBS-washed cells were incubated 
in medium D for 18 h and then chased with or without 50 µg/ml LDL for 
4 h. Cell lysates were processed for immunoprecipitation with rabbit poly-
clonal  anti-NPC1  antibodies.  Input  and  immunoprecipitated  complexes 
were blotted with monoclonal anti-Xpress or anti-NPC1 antibodies. Input 
represents 5% of the whole cell lysates. LBD, ligand binding domain.   
(B) HEK-293 cells grown in medium A were cotransfected with cDNAs encod-
ing full-length ORP5 and pEGFP (Mock), or different NPC1 (WT, P692S, 
D787N). Cell lysates were processed for immunoprecipitation with rabbit 
polyclonal anti-GFP antibodies. Input and the immunoprecipitated com-
plexes were blotted with goat polyclonal anti-ORP5 or anti-GFP antibodies.   
Input  represents  2.5%  of  the  whole  cell  lysates.  The  molecular  mass 
of the proteins is indicated in kilodaltons next to the gel blots. (C) HeLa 
cells grown on coverslips in medium A were cotransfected with mCherry-
ORP5C and EYFP-Lamp1, EYFP-NPC1, or EGFP-FYVE (EEA1) for 48 h and 
processed for fluorescent microscopy. Representative confocal images are 
shown. Bars, 10 µm.
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mislocalization of DsRed­Golgi is corrected when both ORP5 
and NPC1 are knocked down simultaneously (Fig. 5). Why 
would  ORP5  knockdown  have  a  seemingly  more  severe   
phenotype than depleting both ORP5 and NPC1? One possibil­
ity is that when ORP5 is compromised, cholesterol accumulates 
on the limiting membrane, which may affect the retrograde trans­
port to the Golgi that involves the recruitment of coat proteins 
(e.g., retromer) and vesicle budding or tubule formation from 
specific domains on the limiting membrane of LE (Bonifacino 
and Rojas, 2006). As is the case when NPC1 is knocked down, 
lumenal accumulation of cholesterol may not severely disturb 
the physical properties of the limiting membrane, and therefore 
is less  disruptive  to the  retrograde transport pathway. Alter­
natively, though less likely, silencing of ORP5 may impair TGN 
function and disrupt the vesicular transport pathway between 
the LEs and the TGN, indirectly causing cholesterol accumula­
tion in the LE/LY. In this regard, the depletion of TGN­specific 
SNAREs has been shown to reduce the transport of LDL­C by 
>50% (Urano et al., 2008). ORP5, like the yeast ORP Osh4p, 
may also exert its effect on the TGN by modulating the pool of 
PIPs needed for the proper function of Golgi membranes (Fairn 
et al., 2007; Schaaf et al., 2008).
In summary, our results provide the first characterization 
of a novel ORP, ORP5, and uncover an intimate relationship   
between ORP5 and NPC1. Our data support a role for ORP5 in 
the nonvesicular transport of LDL­C from LE/LY to the ER.   
We propose a simple model to speculate on how cholesterol can 
be delivered to the ER from endosomal compartments by ORP5 
(Fig. S4). In response to an increased cholesterol level on the 
limiting  membrane,  LE/LY  may  form  transient  junctions/ 
contact sites with the ER that allow efficient removal of endo­
somal cholesterol by ORP5 (Holthuis and Levine, 2005). NPC1, 
ORP5, or yet­to­be identified proteins may play a structural role 
in establishing such a junction. With direct or indirect assistance 
from NPC1, ORP5 may move cholesterol from LE/LY directly 
to the ER, as ORP5 can transport sterols in vitro (Fig. 2).   
Another interesting protein is the AAA ATPase VPS4/SKD1, 
which has been shown to regulate endosomal cholesterol traf­
ficking  and  also  interact  with  both  yeast  ORPs  and  NPC1 
(Bishop and Woodman, 2000; Wang et al., 2005a; Ohsaki et al., 
2006). Given the molecular function of AAA ATPases, it is 
likely that VPS4/SKD1 may dismantle such a junction once 
cholesterol delivery is completed (Yang, 2006). In this regard, 
VPS4/SKD1 interacts with ORPs and NPC1 much more effi­
ciently upon sterol depletion (Wang et al., 2005a; Ohsaki et al., 
2006). Although the exact nature of the ORP5–NPC1 interaction 
remains to be elucidated, this study identifies for the first time   
a cytoplasmic sterol carrier in NPC1­mediated cholesterol trans­
port. Further characterization of the NPC1–ORP5 pathway should 
shed new light on the molecular function of NPC1 and also on 
the mechanisms of intracellular cholesterol transport.
Materials and methods
Materials
DME, DME/Ham’s Nutrient Mixture F-12 (DME/F12), newborn calf serum 
(NCS), FBS, penicillin–streptomycin, Dulbecco’s PBS, and LipidTOX were 
obtained  from  Invitrogen.  Cholesterol  (5-cholesten-3-ol)  was  obtained 
a SNARE­dependent, vesicular pathway to reach the Golgi be­
fore arriving at the ER, as suggested by recent studies (Urano   
et al., 2008; Ngo and Ridgway, 2009). Here we show for the 
first time that a protein outside of LE/LY, ORP5, is required for 
efficient cholesterol egress from this compartment. We found 
that ORP resides in the ER and interacts with NPC1 in the   
LE/LY membrane, probably at regions of close contact between 
these two organelles. These findings suggest that ORP5 is re­
quired for efficient nonvesicular transfer of LDL­C from LE/LY 
to the ER.
OSBP  and  ORPs  bind  sterols  and  possess  multiple   
membrane­targeting motifs, features well­suited for a role in   
moving cholesterol between membranes. It has recently been dem­
onstrated that for efficient sterol transfer, the ORD domain pres­
ent in all ORPs can simultaneously bind two closely apposed   
membranes, such as the membrane contact sites (Holthuis and 
Levine, 2005; Schulz et al., 2009). The ER is known to form 
contact sites with other organelles, including the mitochondria 
and LE (Kornmann et al., 2009; Eden et al., 2010). A close ap­
position between the ER, but not the Golgi, and NPC1 LE/LY 
has been observed repeatedly (Ko et al., 2001). ORP5 is an ER­
localized, tail­anchored protein that has a PH domain near its   
N terminus. It is therefore likely that ORP5 may operate at the 
membrane contact sites between ER and LE to transfer LDL­C 
directly back to the ER. In support of this, we show that ORP5 
can transport sterols in vitro, that cholesterol accumulates in the 
LE/LY of ORP5­silenced cells, and that ORP5 can make con­
tact with Lamp1­positive LEs. Interestingly, ORP5 and NPC1 
may exist in the same multiprotein complex through direct   
or indirect interactions, as ORP5 and NPC1 can be coimmuno­
precipitated. This raises the possibility that NPC1 may not   
only mediate the incorporation of LDL­C to lysosomal mem­
branes through its interaction with NPC2 in the lysosomal   
lumen, but may also facilitate the extraction of cholesterol by 
ORP5 in the cytoplasm.
An interesting observation is that cholesterol appears to 
accumulate on the limiting membranes of LE/LY upon ORP5 
knockdown. This differs from NPC1 knockdown cells, as when 
NPC1 is absent, the carbohydrate glycocalyx lining the lumenal 
side of the lysosomal membrane would keep NPC2 from inter­
acting with the limiting membrane, preventing cholesterol from 
transiting the glycocalyx and reaching the limiting membrane 
(Kwon et al., 2009). Therefore, cholesterol appears to occupy 
the entire lumenal space of LE/LY in NPC1­depleted cells. With 
a fully functional NPC1 and NPC2, LDL­C should be able to 
reach the limiting membrane, but it stays there if subsequent 
transport machinery is disrupted. ORP5 could be an essential 
component of such machinery, as cholesterol accumulates in the 
limiting membrane upon ORP5 depletion. The fact that knocking 
down both ORP5 and NPC1 exhibits a phenotype that is similar 
to NPC1 knockdown alone suggests that NPC1 may function 
upstream of ORP5: ORP5 depends on NPC1 for its function.
The functional relationship between NPC1 and ORP5 has 
been further supported by examining the localization of Golgi 
markers, including DsRed­Golgi, CI­MPR, and TGN46. These 
markers localize to the Golgi at steady­state in normal cells, but 
are mislocalized to LE/LY upon ORP5 depletion. Interestingly, the JCB • VOLUME 192 • NUMBER 1 • 2011   132
M. Scott (Howard Hughes Medical Institute, Stanford University School of 
Medicine, Stanford, CA).
Subcellular fractionation
HeLa cells grown in two T175 flasks were harvested and homogenized 
using 18 strokes of the pestles of a Dounce homogenizer. Homogenates 
were centrifuged at 750 g for 5 min at 4°C. Postnuclear supernatants were 
collected, applied to a 10–40% Nycomed OptiPrep (Invitrogen) continu-
ous gradient, and centrifuged at 48,000 g in an SW41 rotor for 18 h 
at 4°C. Fractions (0.8 ml) were collected and subjected to SDS-PAGE and 
immunoblotting analysis with antibodies to ORP5, calnexin (ER), lamp-1 
(LE/LY), or -1,4-GT1 (Golgi).
RNAi
siRNA transfection was performed in cells grown in medium A at 25% 
confluence,  according  to  standard  methods  and  using  Lipofectamine 
RNAiMAX transfection reagent (Invitrogen). The targeting sequence of   
siRNAs against NPC1 (QIAGEN) was 5-ACCAATTGTGATAGCAATATT-3, 
and  the  sequence  against  ORP5  (Invitrogen)  was  5-CCCTGCCCAG-
CAGCTACCTGATCTT-3. A Stealth RNAi universal negative control (Invit-
rogen) was used as a negative control in all RNAi transfections. 40 pmol 
of duplexes of siRNA was used for transfection of one well of cells grown 
in a 6-well plate. Cells transfected for 48–72 h were used for filipin stain-
ing, immunofluorescence, immunoblotting, or a cholesterol esterification 
assay. To generate ORP5 RNAi-resistant constructs, silent mutations in the 
siRNA targeting sequence, where AGCAGC (-Ser-Ser-) is replaced by TC-
GTCG (-Ser-Ser-), were produced by two-step QuikChange site-directed 
mutagenesis (Wang and Malcolm, 1999) using the following oligos: for-
ward, 5-ACACAGCCCCTGCCCTCGTCGTACCTGATCTTCAGG-3; and 
reverse, 5-CCTGAAGATCAGGTACGACGAGGGCAGGGGCTGTGT-3.
Filipin staining and fluorescence microscopy
Cells grown on coverslips were fixed with 4% paraformaldehyde for 30 min 
at RT. Cells were stained with freshly prepared 50 µg/ml filipin in PBS for   
1 h at RT. Stained cells were mounted with Prolong Antifade solution (Invit-
rogen) and imaged at room temperature using a microscope (CTR5500) 
equipped with an EL6000 fluorescent lamp and a DFC300 FX digital camera 
(Leica). The filipin signal was visualized with a Cube A filter (a 360/40-nm 
band-pass excitation filter, a 400-nm dichromatic mirror, and a 470/50-nm 
band-pass emission filter; Leica). EGFP/YFP signal was visualized with a GFP 
filter (a 470/40-nm band-pass excitation filter, a 500-nm dichromatic mirror, 
and a 525/50-nm band-pass emission filter; Leica). Images were processed 
using Leica LAS AF software and ImageJ (National Institutes of Health, http://
rsb.info.nih.gov/ij). Quantification of intracellular free cholesterol was per-
formed as described previously (Ge et al., 2008). In brief, outlines of the 
whole cell and the nucleus were manually drawn and the filipin fluorescence 
intensities were measured individually using ImageJ. Intracellular cholesterol 
content was expressed by subtracting the intensity of the nucleus from that of 
the whole cell. Relative intracellular cholesterol was presented by normalizing 
values from transfected cells against those of nontransfected cells, which were 
arbitrarily defined as 1. For each condition, >50 cells were randomly se-
lected and calculated.
In vitro cholesterol transfer
Recombinant protein expression and purification, preparation of liposomes, 
and DHE transfer assay were performed essentially as described previously 
(Schulz et al., 2009). In brief, GST-fused ORP5ORD, expressed in Esche-
richia coli cells, was purified, and the GST-free recombinant protein was 
subsequently prepared and concentrated. All liposomes were prepared in 
standard vesicle buffer (20 mM Hepes, pH 7.3, 100 mM NaCl, and 1 mM 
EDTA). Donor liposomes without PIPs contained 67:20:4:9 PC/PE/PS/DHE, 
and donor liposomes with PIPs contained 67:20:3:1:9 PC/PE/PS/PI(x)P/DHE 
or 67:20:3:0.5:9 PC/PE/PS/PI(x,y)P/DHE. Acceptor liposomes contained 
73.5:20:4:2.5 PC/PE/PS/dansyl-PE. The in vitro sterol transfer assay was 
performed at the same protein and lipid concentrations. The assay was ter-
minated by cooling on ice, and samples were diluted 1:1 immediately   
before  fluorescence  measurement.  All  fluorometric  readings  were  taken   
using a photomultiplier (detector voltage set to 750 W; model 814; Photon 
Technology International [PTI]) with a short arc lamp (75W Xenon; Ushio) as 
a light source. Data were collected and analyzed using the FeliX software 
(version 32; PTI). All readings were taken as 100 µl samples in a 3-mm 
quartz cell (Starna Cells).
Cholesterol measurement
HeLa cells plated in 12-well plates were transfected with the indicated 
siRNA for 54 h, then switched to medium D supplemented with 50 µg/ml 
from  Steraloids.  Protein  A–Sepharose  CL-4B,  [1,2(n)-
3H]-Cholesterol 
(41.0 Ci/mmol), and [1-
14C]-Palmitate (specific activity, 51 mCi/mmol) 
were obtained from GE Healthcare. Lipoprotein-deficient serum was iso-
lated from NCS by ultracentrifugation as described previously (Goldstein 
et al., 1983). LDL was subfractionated by density gradient ultracentrifuga-
tion from the plasma of healthy male volunteers (Brown et al., 1996). Com-
pactin (mevastatin), mevalonate, filipin, saponin, and protease inhibitor 
cocktail were obtained from Sigma-Aldrich. Yeast extract, peptone, glucose, 
tryptone, and yeast nitrogen base were obtained from BD. Zymolase 20T 
was obtained from US Biological. For the in vitro cholesterol transfer assay, 
all lipids were obtained from Avanti Polar Lipids, Inc., except for DHE 
(Sigma-Aldrich),  and  the  di-(16:0)-PI(3)P  and  di-(16:0)-PI(3,5)P2,  which 
were obtained from Echelon Biosciences Inc.
Split-ubiquitin yeast two-hybrid assay
The  bait  and  prey  constructs  for  the  split-ubiquitin  yeast  two-hybrid   
(sp-ubY2H) system (Dualsystems Biotech AG) was made by subcloning the 
cDNAs encoding full-length proteins (Ncr1p and Osh proteins, respec-
tively)  into  the  appropriate  vectors.  The  sp-ubY2H  screening  was  per-
formed according to the manufacturer’s instructions. To construct the arv1 
strain, a PCR-based homologous recombination method was used to delete 
the entire coding sequence of ARV1, replacing it with a kanamycin cas-
sette. The resultant strain was confirmed by diagnostic PCR and temperature-
sensitive phenotype.
Cell culture and transfection
CHO-K1 cells were a gift of M.S. Brown and J.L. Goldstein (University of 
Texas Southwestern Medical Center at Dallas, Dallas, TX). The 2-2 NPC1-
defective cells, which contain an extra nucleotide at position 1335 of 
NPC1, resulting in a frameshift and early translation termination after the 
450th amino acid (Wojtanik and Liscum, 2003), were provided by L. Liscum 
(Tufts University, Boston, MA). HEK-293 cells were a gift of D. James   
(Garvan Institute, Sydney, Australia). HeLa cells were purchased from the 
American  Type  Culture  Collection  (ATCC  HTB-22).  Monolayers  of  cells 
were maintained in specified medium supplemented with 10% serum,   
100 U/ml penicillin, and 100 µg/ml streptomycin sulfate in 5% CO2 at 37°C. 
For HeLa and HEK-293 cells, DME and 10% FBS (medium A) were used; 
for CHO-K1 and Npc1-null 2-2 cells, the 1:1 mixture of DME/F12 and 
10% NCS (medium B) was used. For cholesterol starvation treatments, PBS-
rinsed cells were cultured overnight in medium containing 5% lipoprotein-
deficient serum instead of NCS or FBS (medium C), plus 10 µM mevastatin 
and 50 µM mevalonate (medium D). Cell transfection was performed using 
Lipofectamine LTX and Plus Reagent (Invitrogen) according to manufacturer’s 
instructions. For each transfection, 1–2 µg/well of cDNA was used in 6-well 
plates, and 5–10 µg/dish of cDNA was used in 100-mm dishes.
Antibodies
Antibodies used were goat polyclonal to ORP5 (Abcam) and -1,4-galactosyl-
transferase I (-1,4-GT1; Santa Cruz Biotechnology, Inc.), rabbit polyclonal 
to the C-terminal region of human NPC1 and golgin 97 (Abcam), GFP   
(Invitrogen), syntaxin 5 (Subramaniam et al., 1997), calnexin (Cell Signal-
ing Technology), DsRed (Takara Bio, Inc.), giantin (Covance), and TGN46 
(AbD  Serotec),  mouse  monoclonal  to  the  Xpress  tag  (Invitrogen),  actin   
(Abcam), GST, Lamp-1 and GFP (Santa Cruz Biotechnology, Inc.), and GM130 
(BD). For immunoblotting, we obtained horseradish peroxidase–conjugated 
secondary antibodies from Jackson ImmunoResearch Laboratories, Inc. For 
immunofluorescence, we obtained Alexa Fluor–conjugated secondary anti-
bodies from Invitrogen.
cDNA constructs
pcDNA4-ORP5LBD  encoding  the  Xpress  epitope-tagged  C  terminus  of 
ORP5 ligand-binding domain was a gift from V. Olkkonen (National Public 
Health Institute, Helsinki, Finland). The full-length human ORP5 and ORP8 
open reading frames were obtained from Thermo Fisher Scientific and 
cloned into pGEX-4T-1, pcDNA4/HisMaxC (Invitrogen), pEGFP-C1, or   
pmCherry-C1 vectors (Takara Bio Inc.) by standard subcloning procedures: 
pGST-ORP5ORD encodes N-terminal GST fusion of human ORP5 ORD 
(266–826),  pcDNA4-ORP5  encodes  N-terminal  Xpress  epitope-tagged 
ORP5, and pmCherry-ORP5 and pmCherry-ORP8 encode the correspond-
ing proteins with fluorescence protein tagged to the N termini. DsRed2-ER 
and pDsRed-Monomer-Golgi (N-terminal 81 amino acids of -1,4-GT1) 
were obtained from Takara Bio Inc. pEGFP-FYVE and pEYFP-Lamp1 were 
gifts  from  R.  Teasdale  (Institute  of  Molecular  Bioscience,  University  of 
Queensland, Queensland, Australia). NPC1-FP constructs encoding mouse 
NPC1 with YFP fused to the C terminus of the protein were provided by   133 ORP5 and endosomal cholesterol trafficking • Du et al.
presence of various concentrations of ergosterol, the beads (bound frac-
tion) were spun down and washed three times with ice-cold yeast extrac-
tion buffer (0.3 M NaCl and 1 PBS containing 1% Triton X-100). The 
bound proteins were then eluted from beads with SDS-PAGE sample buffer 
by heating at 95°C for 3 min, followed by immunoblot analysis.
Immunoblot analysis
Immunoblotting analysis was performed as described previously (Du et al., 
2006), with minor modifications. In brief, after electrophoresis, the pro-
teins were transferred to Hybond-C nitrocellulose filters (GE Healthcare). 
Incubations with primary antibodies were performed at 4°C overnight or 
RT for 1 h. Secondary antibodies were peroxidase-conjugated AffiniPure 
donkey  anti–rabbit  or  donkey  anti–mouse  IgG  (H+L;  Jackson  Immuno-
Research Laboratories, Inc.) used at a 1:5,000 dilution. The bound antibodies 
were visualized by ECL Western blotting detection reagent (GE Healthcare). 
The filters were exposed to Hyperfilm ECL (GE Healthcare) for periods of   
2 s to 3 min.
Statistical analyses
Statistical  analysis  between  groups  was  performed  using  Prism  5  for   
Windows version 5.02 (GraphPad Software) with a Student’s t test. Data 
are expressed as mean + SD unless otherwise stated. Significant differ-
ences are indicated in the figures.
Online supplemental material
Fig. S1 shows that yeast Ncr1p and Osh6/7p interact in the split-ubiquitin 
yeast two-hybrid system. Fig. S2 shows that ORP5 knockdown had no ef-
fects on lipid droplet formation, the ER structure, and the Golgi complex   
integrity. Fig. S3 shows that ORP5 overexpression rescues the mislocaliza-
tion of DsRed-Golgin in ORP5 knockdown cells and that NPC1 is coimmuno-
precipitated with ORP5LBD in HEK293 cells. Fig. S4 shows a hypothetical 
model of how cholesterol can be delivered to the ER from endosomal 
compartments by ORP5. Fig. S5 displays original images showing the 
details of filipin staining in NPC1 knockdown and ORP5 knockdown cells, 
respectively. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201004142/DC1.
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